Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-01

AUTHORS

Hideki Kato, Yoshitaka Miyakawa, Yoshihiko Hidaka, Norimitsu Inoue, Shuichi Ito, Shoji Kagami, Shinya Kaname, Masanori Matsumoto, Masashi Mizuno, Takahisa Matsuda, Akihiko Shimono, Shoichi Maruyama, Yoshihiro Fujimura, Masaomi Nangaku, Hirokazu Okada

ABSTRACT

BACKGROUND: Eculizumab has been available for the treatment of atypical hemolytic-uremic syndrome (aHUS) in Japan since 2013. To assess safety and effectiveness of eculizumab in adult aHUS patients in the real-life setting, we performed interim analysis of a post-marketing surveillance mandated by Japanese regulations. METHODS: This study enrolled any patient who was diagnosed with TMA excluding Shiga toxin-producing Escherichia coli-HUS or thrombotic thrombocytopenic purpura based on Japanese clinical guide published in 2013 as inclusion criteria and treated with eculizumab. Although the term aHUS was redefined to denote only complement-mediated HUS in the guide revised in 2016, the patients with TMA caused by other causes (secondary TMA) were included. Patient outcomes and safety were evaluated at 6 months, 12 months, and annually thereafter. RESULTS: Thirty-three patients with aHUS and 27 patients with secondary TMA were enrolled. Median treatment duration of aHUS was 24weeks. Complement genes variants were detected in 11 of 18 patients with aHUS (61.1%). Among the 29 aHUS patients with available baseline data, platelet count (PLT), lactic dehydrogenase and serum creatinine (SCr) improved within 1-month after eculizumab initiation. TMA event-free status, complete TMA response, PLT normalization, and SCr decrease were achieved in 67.9% (19/28), 27.8% (5/18), 56.5% (13/23), and 57.1% (16/28) of patients, respectively. Thirty-three and 11 adverse reactions were observed in patients with aHUS (13/33 patients) and secondary TMA (6/27 patients), respectively. CONCLUSIONS: This interim analysis confirmed the acceptable safety profile and effectiveness of eculizumab for Japanese adult aHUS patients in real-world settings. More... »

PAGES

1-11

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10157-018-1609-8

DOI

http://dx.doi.org/10.1007/s10157-018-1609-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105208689

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29959568


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Division of Nephrology and Endocrinology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kato", 
        "givenName": "Hideki", 
        "id": "sg:person.01275753007.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275753007.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saitama Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410802.f", 
          "name": [
            "Department of General Internal Medicine, Thrombosis and Hemostasis Center, Saitama Medical University, 38 Moroyama, Iruma-gun, 350-0495, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyakawa", 
        "givenName": "Yoshitaka", 
        "id": "sg:person.01317475506.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317475506.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shinshu University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412568.c", 
          "name": [
            "Clinical Division of Pediatrics, Shinshu University Hospital, 3-1-1 Asahi, 390-8621, Matsumoto, Nagano, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hidaka", 
        "givenName": "Yoshihiko", 
        "id": "sg:person.01366756522.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366756522.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Osaka International Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.489169.b", 
          "name": [
            "Department of Tumor Immunology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, 541-8567, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inoue", 
        "givenName": "Norimitsu", 
        "id": "sg:person.010564733752.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010564733752.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yokohama City University", 
          "id": "https://www.grid.ac/institutes/grid.268441.d", 
          "name": [
            "Department of Pediatrics, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanasawa-ku, 236-0004, Yokohama, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ito", 
        "givenName": "Shuichi", 
        "id": "sg:person.012302533312.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012302533312.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokushima", 
          "id": "https://www.grid.ac/institutes/grid.267335.6", 
          "name": [
            "Department of Pediatrics, Institute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto cho 3-chome, 770-8503, Tokushima, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kagami", 
        "givenName": "Shoji", 
        "id": "sg:person.01227336036.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227336036.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kyorin University", 
          "id": "https://www.grid.ac/institutes/grid.411205.3", 
          "name": [
            "Department of Nephrology and Rheumatology, Kyorin University School of Medicine, 6-20-2 Shinkawa, 181-8611, Mitaka, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaname", 
        "givenName": "Shinya", 
        "id": "sg:person.0632351573.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632351573.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nara Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410814.8", 
          "name": [
            "Department of Blood Transfusion Medicine, Nara Medical University, 840 Shijyo-cho, 634-8522, Kashihara, Nara, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsumoto", 
        "givenName": "Masanori", 
        "id": "sg:person.013301731152.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013301731152.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University", 
          "id": "https://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Renal Replacement Therapy, Division of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mizuno", 
        "givenName": "Masashi", 
        "id": "sg:person.01211430102.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211430102.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Alexion Pharma GK, 1-18-14 Ebisu, Shibuya-ku, 150-0013, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsuda", 
        "givenName": "Takahisa", 
        "id": "sg:person.014167142054.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014167142054.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Alexion Pharma GK, 1-18-14 Ebisu, Shibuya-ku, 150-0013, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimono", 
        "givenName": "Akihiko", 
        "id": "sg:person.014764522454.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014764522454.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagoya University", 
          "id": "https://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maruyama", 
        "givenName": "Shoichi", 
        "id": "sg:person.01106355134.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106355134.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Japanese Red Cross Kinki Block Blood Center, 7-5-17, Saitoasagi, 567-0085, Ibaraki, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fujimura", 
        "givenName": "Yoshihiro", 
        "id": "sg:person.0724065021.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724065021.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Division of Nephrology and Endocrinology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nangaku", 
        "givenName": "Masaomi", 
        "id": "sg:person.01300062465.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300062465.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saitama Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410802.f", 
          "name": [
            "Department of Nephrology, Saitama Medical University, 38 Moroyama, Iruma-gun, 350-0495, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okada", 
        "givenName": "Hirokazu", 
        "id": "sg:person.0700630035.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700630035.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1053/j.ajkd.2008.12.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000437042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.kint.2016.10.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001194540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/kisup.2012.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004822134", 
          "https://doi.org/10.1038/kisup.2012.1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-013-0911-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015777021", 
          "https://doi.org/10.1007/s10157-013-0911-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2215/cjn.02210310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015844186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-6143.2008.02297.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016959283"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-016-1276-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023786470", 
          "https://doi.org/10.1007/s10157-016-1276-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-016-1276-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023786470", 
          "https://doi.org/10.1007/s10157-016-1276-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-016-1276-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023786470", 
          "https://doi.org/10.1007/s10157-016-1276-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2215/cjn.04760512", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031732423"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ki.2014.423", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034487753", 
          "https://doi.org/10.1038/ki.2014.423"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1681/asn.2009070706", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037766154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1681/asn.2009070706", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037766154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-09-600411", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038634364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1208981", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038836296"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ped.12274", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041431327"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2015-08-663435", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045520489"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ped.13044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045648041"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ajt.12077", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046014554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.ajkd.2015.12.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046980700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/gfw453", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059933581"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079365600", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.kint.2016.12.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083699939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2215/cjn.00280117", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085942289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2215/cjn.00280117", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085942289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.kint.2017.06.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091576704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci.insight.99128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101679438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci.insight.99128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101679438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci.insight.99128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101679438"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01", 
    "datePublishedReg": "2019-01-01", 
    "description": "BACKGROUND: Eculizumab has been available for the treatment of atypical hemolytic-uremic syndrome (aHUS) in Japan since 2013. To assess safety and effectiveness of eculizumab in adult aHUS patients in the real-life setting, we performed interim analysis of a post-marketing surveillance mandated by Japanese regulations.\nMETHODS: This study enrolled any patient who was diagnosed with TMA excluding Shiga toxin-producing Escherichia coli-HUS or thrombotic thrombocytopenic purpura based on Japanese clinical guide published in 2013 as inclusion criteria and treated with eculizumab. Although the term aHUS was redefined to denote only complement-mediated HUS in the guide revised in 2016, the patients with TMA caused by other causes (secondary TMA) were included. Patient outcomes and safety were evaluated at 6 months, 12 months, and annually thereafter.\nRESULTS: Thirty-three patients with aHUS and 27 patients with secondary TMA were enrolled. Median treatment duration of aHUS was 24weeks. Complement genes variants were detected in 11 of 18 patients with aHUS (61.1%). Among the 29 aHUS patients with available baseline data, platelet count (PLT), lactic dehydrogenase and serum creatinine (SCr) improved within 1-month after eculizumab initiation. TMA event-free status, complete TMA response, PLT normalization, and SCr decrease were achieved in 67.9% (19/28), 27.8% (5/18), 56.5% (13/23), and 57.1% (16/28) of patients, respectively. Thirty-three and 11 adverse reactions were observed in patients with aHUS (13/33 patients) and secondary TMA (6/27 patients), respectively.\nCONCLUSIONS: This interim analysis confirmed the acceptable safety profile and effectiveness of eculizumab for Japanese adult aHUS patients in real-world settings.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10157-018-1609-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1117096", 
        "issn": [
          "1342-1751", 
          "1437-7799"
        ], 
        "name": "Clinical and Experimental Nephrology", 
        "type": "Periodical"
      }
    ], 
    "name": "Safety and effectiveness of eculizumab for adult patients with atypical hemolytic\u2013uremic syndrome in Japan: interim analysis of post-marketing surveillance", 
    "pagination": "1-11", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "097fa277641a8a6a8473816580d04c05f4b3820dcc4df87594e0231847aa3dfc"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29959568"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9709923"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10157-018-1609-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105208689"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10157-018-1609-8", 
      "https://app.dimensions.ai/details/publication/pub.1105208689"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8684_00000557.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs10157-018-1609-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10157-018-1609-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10157-018-1609-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10157-018-1609-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10157-018-1609-8'


 

This table displays all metadata directly associated to this object as RDF triples.

265 TRIPLES      21 PREDICATES      50 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10157-018-1609-8 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author Na42318fe637a41d492c40583c7ec029c
4 schema:citation sg:pub.10.1007/s10157-013-0911-8
5 sg:pub.10.1007/s10157-016-1276-6
6 sg:pub.10.1038/ki.2014.423
7 sg:pub.10.1038/kisup.2012.1
8 https://app.dimensions.ai/details/publication/pub.1079365600
9 https://doi.org/10.1016/j.kint.2016.10.005
10 https://doi.org/10.1016/j.kint.2016.12.009
11 https://doi.org/10.1016/j.kint.2017.06.022
12 https://doi.org/10.1053/j.ajkd.2008.12.034
13 https://doi.org/10.1053/j.ajkd.2015.12.034
14 https://doi.org/10.1056/nejmoa1208981
15 https://doi.org/10.1093/ndt/gfw453
16 https://doi.org/10.1111/ajt.12077
17 https://doi.org/10.1111/j.1600-6143.2008.02297.x
18 https://doi.org/10.1111/ped.12274
19 https://doi.org/10.1111/ped.13044
20 https://doi.org/10.1172/jci.insight.99128
21 https://doi.org/10.1182/blood-2014-09-600411
22 https://doi.org/10.1182/blood-2015-08-663435
23 https://doi.org/10.1681/asn.2009070706
24 https://doi.org/10.2215/cjn.00280117
25 https://doi.org/10.2215/cjn.02210310
26 https://doi.org/10.2215/cjn.04760512
27 schema:datePublished 2019-01
28 schema:datePublishedReg 2019-01-01
29 schema:description BACKGROUND: Eculizumab has been available for the treatment of atypical hemolytic-uremic syndrome (aHUS) in Japan since 2013. To assess safety and effectiveness of eculizumab in adult aHUS patients in the real-life setting, we performed interim analysis of a post-marketing surveillance mandated by Japanese regulations. METHODS: This study enrolled any patient who was diagnosed with TMA excluding Shiga toxin-producing Escherichia coli-HUS or thrombotic thrombocytopenic purpura based on Japanese clinical guide published in 2013 as inclusion criteria and treated with eculizumab. Although the term aHUS was redefined to denote only complement-mediated HUS in the guide revised in 2016, the patients with TMA caused by other causes (secondary TMA) were included. Patient outcomes and safety were evaluated at 6 months, 12 months, and annually thereafter. RESULTS: Thirty-three patients with aHUS and 27 patients with secondary TMA were enrolled. Median treatment duration of aHUS was 24weeks. Complement genes variants were detected in 11 of 18 patients with aHUS (61.1%). Among the 29 aHUS patients with available baseline data, platelet count (PLT), lactic dehydrogenase and serum creatinine (SCr) improved within 1-month after eculizumab initiation. TMA event-free status, complete TMA response, PLT normalization, and SCr decrease were achieved in 67.9% (19/28), 27.8% (5/18), 56.5% (13/23), and 57.1% (16/28) of patients, respectively. Thirty-three and 11 adverse reactions were observed in patients with aHUS (13/33 patients) and secondary TMA (6/27 patients), respectively. CONCLUSIONS: This interim analysis confirmed the acceptable safety profile and effectiveness of eculizumab for Japanese adult aHUS patients in real-world settings.
30 schema:genre research_article
31 schema:inLanguage en
32 schema:isAccessibleForFree true
33 schema:isPartOf sg:journal.1117096
34 schema:name Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
35 schema:pagination 1-11
36 schema:productId N0b235ba3b2664b648cbcee11a0b50e76
37 N28b9823ef7ee4f5eb9e26fe27d8a7213
38 N4c3718b7c6e34d3c948354060ea9f3ce
39 N888ceb4983e84ce3ab6cc482de320a90
40 Nf6f47e1a485f471bbffaba6ed1e627a1
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105208689
42 https://doi.org/10.1007/s10157-018-1609-8
43 schema:sdDatePublished 2019-04-10T20:54
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N3b60425e7d48407ba80857a3e5c61c20
46 schema:url https://link.springer.com/10.1007%2Fs10157-018-1609-8
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N0a8c976aa7ad4d719d4b504d1c15a321 rdf:first sg:person.0700630035.01
51 rdf:rest rdf:nil
52 N0b235ba3b2664b648cbcee11a0b50e76 schema:name nlm_unique_id
53 schema:value 9709923
54 rdf:type schema:PropertyValue
55 N28b9823ef7ee4f5eb9e26fe27d8a7213 schema:name doi
56 schema:value 10.1007/s10157-018-1609-8
57 rdf:type schema:PropertyValue
58 N3b60425e7d48407ba80857a3e5c61c20 schema:name Springer Nature - SN SciGraph project
59 rdf:type schema:Organization
60 N45677578195c4fc4aaac1dd56e929465 schema:name Alexion Pharma GK, 1-18-14 Ebisu, Shibuya-ku, 150-0013, Tokyo, Japan
61 rdf:type schema:Organization
62 N4c3718b7c6e34d3c948354060ea9f3ce schema:name readcube_id
63 schema:value 097fa277641a8a6a8473816580d04c05f4b3820dcc4df87594e0231847aa3dfc
64 rdf:type schema:PropertyValue
65 N52f050369f42422bb15c6156a7cbb6b7 schema:name Japanese Red Cross Kinki Block Blood Center, 7-5-17, Saitoasagi, 567-0085, Ibaraki, Osaka, Japan
66 rdf:type schema:Organization
67 N632d7d62351c451cad79c8814a2ddb11 rdf:first sg:person.014764522454.27
68 rdf:rest N65419d3fa8514253bd9361101ac55b31
69 N65419d3fa8514253bd9361101ac55b31 rdf:first sg:person.01106355134.42
70 rdf:rest Nbbb4008b1b764301acc07d03d86590b6
71 N81e3aa4ca9e644199370485788c54be6 rdf:first sg:person.014167142054.61
72 rdf:rest N632d7d62351c451cad79c8814a2ddb11
73 N888ceb4983e84ce3ab6cc482de320a90 schema:name pubmed_id
74 schema:value 29959568
75 rdf:type schema:PropertyValue
76 N8b63d17ab39a4c48827d7f3260e8f5e9 rdf:first sg:person.013301731152.54
77 rdf:rest Ne1c51469d09345078a42263de8084920
78 N922a1fb910a245b1a810f27d414137d5 rdf:first sg:person.01317475506.36
79 rdf:rest Nbafe4373a5d345dea200677ed9f97df4
80 Na42318fe637a41d492c40583c7ec029c rdf:first sg:person.01275753007.55
81 rdf:rest N922a1fb910a245b1a810f27d414137d5
82 Naac4859e79984e62aab63550ccd68c03 rdf:first sg:person.01227336036.26
83 rdf:rest Nc0f4c401a39b442186572538cdd689b6
84 Nbafe4373a5d345dea200677ed9f97df4 rdf:first sg:person.01366756522.36
85 rdf:rest Ne15937481ad04b33ad827722a6d78083
86 Nbbb4008b1b764301acc07d03d86590b6 rdf:first sg:person.0724065021.42
87 rdf:rest Ned9a1d9b5b57433b8d6982d8a5cc31f4
88 Nc0992eb703b64cc68cb7afe2ec38ee4c rdf:first sg:person.012302533312.63
89 rdf:rest Naac4859e79984e62aab63550ccd68c03
90 Nc0f4c401a39b442186572538cdd689b6 rdf:first sg:person.0632351573.32
91 rdf:rest N8b63d17ab39a4c48827d7f3260e8f5e9
92 Nd8ccd3fe018443399040531341796044 schema:name Alexion Pharma GK, 1-18-14 Ebisu, Shibuya-ku, 150-0013, Tokyo, Japan
93 rdf:type schema:Organization
94 Ne15937481ad04b33ad827722a6d78083 rdf:first sg:person.010564733752.03
95 rdf:rest Nc0992eb703b64cc68cb7afe2ec38ee4c
96 Ne1c51469d09345078a42263de8084920 rdf:first sg:person.01211430102.94
97 rdf:rest N81e3aa4ca9e644199370485788c54be6
98 Ned9a1d9b5b57433b8d6982d8a5cc31f4 rdf:first sg:person.01300062465.65
99 rdf:rest N0a8c976aa7ad4d719d4b504d1c15a321
100 Nf6f47e1a485f471bbffaba6ed1e627a1 schema:name dimensions_id
101 schema:value pub.1105208689
102 rdf:type schema:PropertyValue
103 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
104 schema:name Medical and Health Sciences
105 rdf:type schema:DefinedTerm
106 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
107 schema:name Public Health and Health Services
108 rdf:type schema:DefinedTerm
109 sg:journal.1117096 schema:issn 1342-1751
110 1437-7799
111 schema:name Clinical and Experimental Nephrology
112 rdf:type schema:Periodical
113 sg:person.010564733752.03 schema:affiliation https://www.grid.ac/institutes/grid.489169.b
114 schema:familyName Inoue
115 schema:givenName Norimitsu
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010564733752.03
117 rdf:type schema:Person
118 sg:person.01106355134.42 schema:affiliation https://www.grid.ac/institutes/grid.27476.30
119 schema:familyName Maruyama
120 schema:givenName Shoichi
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106355134.42
122 rdf:type schema:Person
123 sg:person.01211430102.94 schema:affiliation https://www.grid.ac/institutes/grid.27476.30
124 schema:familyName Mizuno
125 schema:givenName Masashi
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211430102.94
127 rdf:type schema:Person
128 sg:person.01227336036.26 schema:affiliation https://www.grid.ac/institutes/grid.267335.6
129 schema:familyName Kagami
130 schema:givenName Shoji
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227336036.26
132 rdf:type schema:Person
133 sg:person.012302533312.63 schema:affiliation https://www.grid.ac/institutes/grid.268441.d
134 schema:familyName Ito
135 schema:givenName Shuichi
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012302533312.63
137 rdf:type schema:Person
138 sg:person.01275753007.55 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
139 schema:familyName Kato
140 schema:givenName Hideki
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275753007.55
142 rdf:type schema:Person
143 sg:person.01300062465.65 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
144 schema:familyName Nangaku
145 schema:givenName Masaomi
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300062465.65
147 rdf:type schema:Person
148 sg:person.01317475506.36 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
149 schema:familyName Miyakawa
150 schema:givenName Yoshitaka
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317475506.36
152 rdf:type schema:Person
153 sg:person.013301731152.54 schema:affiliation https://www.grid.ac/institutes/grid.410814.8
154 schema:familyName Matsumoto
155 schema:givenName Masanori
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013301731152.54
157 rdf:type schema:Person
158 sg:person.01366756522.36 schema:affiliation https://www.grid.ac/institutes/grid.412568.c
159 schema:familyName Hidaka
160 schema:givenName Yoshihiko
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366756522.36
162 rdf:type schema:Person
163 sg:person.014167142054.61 schema:affiliation N45677578195c4fc4aaac1dd56e929465
164 schema:familyName Matsuda
165 schema:givenName Takahisa
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014167142054.61
167 rdf:type schema:Person
168 sg:person.014764522454.27 schema:affiliation Nd8ccd3fe018443399040531341796044
169 schema:familyName Shimono
170 schema:givenName Akihiko
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014764522454.27
172 rdf:type schema:Person
173 sg:person.0632351573.32 schema:affiliation https://www.grid.ac/institutes/grid.411205.3
174 schema:familyName Kaname
175 schema:givenName Shinya
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632351573.32
177 rdf:type schema:Person
178 sg:person.0700630035.01 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
179 schema:familyName Okada
180 schema:givenName Hirokazu
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700630035.01
182 rdf:type schema:Person
183 sg:person.0724065021.42 schema:affiliation N52f050369f42422bb15c6156a7cbb6b7
184 schema:familyName Fujimura
185 schema:givenName Yoshihiro
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724065021.42
187 rdf:type schema:Person
188 sg:pub.10.1007/s10157-013-0911-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015777021
189 https://doi.org/10.1007/s10157-013-0911-8
190 rdf:type schema:CreativeWork
191 sg:pub.10.1007/s10157-016-1276-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023786470
192 https://doi.org/10.1007/s10157-016-1276-6
193 rdf:type schema:CreativeWork
194 sg:pub.10.1038/ki.2014.423 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034487753
195 https://doi.org/10.1038/ki.2014.423
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/kisup.2012.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004822134
198 https://doi.org/10.1038/kisup.2012.1
199 rdf:type schema:CreativeWork
200 https://app.dimensions.ai/details/publication/pub.1079365600 schema:CreativeWork
201 https://doi.org/10.1016/j.kint.2016.10.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001194540
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/j.kint.2016.12.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083699939
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.kint.2017.06.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091576704
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1053/j.ajkd.2008.12.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000437042
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1053/j.ajkd.2015.12.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046980700
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1056/nejmoa1208981 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038836296
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1093/ndt/gfw453 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059933581
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1111/ajt.12077 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046014554
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1111/j.1600-6143.2008.02297.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016959283
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1111/ped.12274 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041431327
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1111/ped.13044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045648041
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1172/jci.insight.99128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101679438
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1182/blood-2014-09-600411 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038634364
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1182/blood-2015-08-663435 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045520489
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1681/asn.2009070706 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037766154
230 rdf:type schema:CreativeWork
231 https://doi.org/10.2215/cjn.00280117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085942289
232 rdf:type schema:CreativeWork
233 https://doi.org/10.2215/cjn.02210310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015844186
234 rdf:type schema:CreativeWork
235 https://doi.org/10.2215/cjn.04760512 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031732423
236 rdf:type schema:CreativeWork
237 https://www.grid.ac/institutes/grid.267335.6 schema:alternateName University of Tokushima
238 schema:name Department of Pediatrics, Institute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto cho 3-chome, 770-8503, Tokushima, Japan
239 rdf:type schema:Organization
240 https://www.grid.ac/institutes/grid.268441.d schema:alternateName Yokohama City University
241 schema:name Department of Pediatrics, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanasawa-ku, 236-0004, Yokohama, Kanagawa, Japan
242 rdf:type schema:Organization
243 https://www.grid.ac/institutes/grid.26999.3d schema:alternateName University of Tokyo
244 schema:name Division of Nephrology and Endocrinology, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan
245 rdf:type schema:Organization
246 https://www.grid.ac/institutes/grid.27476.30 schema:alternateName Nagoya University
247 schema:name Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan
248 Renal Replacement Therapy, Division of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Aichi, Japan
249 rdf:type schema:Organization
250 https://www.grid.ac/institutes/grid.410802.f schema:alternateName Saitama Medical University
251 schema:name Department of General Internal Medicine, Thrombosis and Hemostasis Center, Saitama Medical University, 38 Moroyama, Iruma-gun, 350-0495, Saitama, Japan
252 Department of Nephrology, Saitama Medical University, 38 Moroyama, Iruma-gun, 350-0495, Saitama, Japan
253 rdf:type schema:Organization
254 https://www.grid.ac/institutes/grid.410814.8 schema:alternateName Nara Medical University
255 schema:name Department of Blood Transfusion Medicine, Nara Medical University, 840 Shijyo-cho, 634-8522, Kashihara, Nara, Japan
256 rdf:type schema:Organization
257 https://www.grid.ac/institutes/grid.411205.3 schema:alternateName Kyorin University
258 schema:name Department of Nephrology and Rheumatology, Kyorin University School of Medicine, 6-20-2 Shinkawa, 181-8611, Mitaka, Tokyo, Japan
259 rdf:type schema:Organization
260 https://www.grid.ac/institutes/grid.412568.c schema:alternateName Shinshu University Hospital
261 schema:name Clinical Division of Pediatrics, Shinshu University Hospital, 3-1-1 Asahi, 390-8621, Matsumoto, Nagano, Japan
262 rdf:type schema:Organization
263 https://www.grid.ac/institutes/grid.489169.b schema:alternateName Osaka International Cancer Institute
264 schema:name Department of Tumor Immunology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, 541-8567, Osaka, Japan
265 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...